Pre-symptomatic spinal muscular atrophy: a proposed nosology

This is the authors' abstract. We don't add key points for this paper.

Finkel and Benatar highlight the ambiguity of the term ‘pre-symptomatic’ when characterizing infants at genetic risk for spinal muscular atrophy. They propose a conceptual framework that recognizes clinically silent and prodromal stages of pre-symptomatic disease and also accommodates emerging prognostic biomarkers.